SENSEONICSHOLDINGS,INC. (NYSEMKT:SENS) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
Senseonics Holdings,Inc. (the Company) is
furnishing an updated corporate presentation, which the Company
may use from time to time in conversations with investors and
analysts beginning January9, 2017. A copy of the presentation is
being furnished as Exhibit99.1 to this Current Report on Form8-K.
The information in this Item 7.01 of this Current Report on
Form8-K (including Exhibit99.1) is being furnished and shall not
be deemed filed for purposes of Section18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act), or
otherwise subject to the liabilities of that Section, nor shall
it be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except
as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and
Exhibits.
(d) Exhibits.
|
Exhibit |
|
|
|
Number |
|
Description |
|
99.1 |
Senseonics Investor Presentation datedJanuary2017. |
About SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS)
Senseonics Holdings, Inc., formerly ASN Technologies, Inc., is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days. Eversense consists of three components: a small sensor inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user’s mobile device, such as a smartphone, Apple Watch or tablet. SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS) Recent Trading Information
SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS) closed its last trading session down -0.14 at 2.70 with 206,736 shares trading hands.